December 4, 2017
19 abstracts on clinical research conducted by top affiliated investigators are scheduled for presentation The Woodlands, Texas (December 4, 2017) – At the 59th American Society of Hematology Annual Meeting and Exposition (ASH), leading investigators from The US Oncology Network and US Oncology Research will showcase detailed findings from 19 studies (four orals, 14 poster […]
Read MoreNovember 28, 2017
Dr. Akbari, a pioneer in breast cancer surgery, brings new line of treatment services to the clinic Fairfax, Va. (November 28, 2017) —Virginia Cancer Specialists (VCS) announced that Stephanie Akbari, MD, FACS, has joined the practice. VCS, a practice in The US Oncology Network, is a premier cancer care and research center in Northern Virginia […]
Read MoreNovember 3, 2017
Affiliation enhances care at both practices, expanding Maryland Oncology Hematology’s services into the Baltimore–Washington Metropolitan Area Columbia, Md. (November 3, 2017) — Maryland Oncology Hematology (MOH), a premier provider of community-based advanced cancer care services throughout the Maryland/Washington D.C. region and an affiliate of The US Oncology Network (The Network), announced that Frederick Oncology & […]
Read MoreNovember 2, 2017
Organization celebrates enrolling 70,000 patients to clinical trials, contributing to more than 70 FDA cancer therapy approvals The Woodlands, Texas (Nov. 2, 2017) — US Oncology Research is holding its 16th Annual Science Forum on November 2-3 in Dallas, an annual meeting that brings together more than 150 affiliated US Oncology Research physician researchers and […]
Read MoreSeptember 19, 2017
Mobile, Ala. (September 19, 2017) – Southern Cancer Center (SCC), a premier oncology clinic in Alabama and a practice in The US Oncology Network, is the first site in the world to open enrollment for a new clinical trial for newly diagnosed kidney cancer patients. This phase 3 clinical trial will look at various investigational […]
Read MoreSeptember 12, 2017
NERLYNXTM is a new treatment option for early-stage HER2+ breast cancer patients following adjuvant trastuzumab-based therapy in the extended adjuvant setting The Woodlands, Texas (September 12, 2017) — Early-stage breast cancer patients with HER2-positive tumors now have a promising new anti-HER2 treatment option in the extended adjuvant setting, thanks in large part to the efforts […]
Read MoreAugust 1, 2017
Eligible Patients to be Directed to Epizyme’s Ongoing Phase 2 Clinical Trial of Tazemetostat in Follicular Lymphoma and Diffuse Large B-cell Lymphoma THE WOODLANDS, Texas and CAMBRIDGE, Mass. (August 1, 2017) – Epizyme, Inc. (NASDAQ: EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, and US Oncology Research, one of the nation’s largest networks of […]
Read MoreJune 23, 2017
Intensive workshop provided resources, expertise to help practices succeed with the Oncology Care Model, MIPS and other alternative payment programs The Woodlands, Texas (June 23, 2017) — The US Oncology Network (The Network) hosted its second annual boot camp last month in Dallas, focusing on various value-based care delivery and reimbursement models. The intensive two-day […]
Read MoreJune 14, 2017
Expanded agreement enhances Value Pathways, providing physicians access to the most recent evidence available for five additional disease states The Woodlands, Texas (June 14, 2017)— McKesson and The US Oncology Network (The Network) have expanded their agreement with the National Comprehensive Cancer Network® (NCCN®), adding five additional disease states to Value Pathways powered by NCCN. […]
Read MoreJune 13, 2017
New facility developed by Ryan Companies US, Inc. offers leading-edge cancer care to growing East Valley region Tempe, Ariz. (June 13, 2017) — Arizona Oncology’s new state-of-the-art cancer treatment center, located at the Arizona State University Research Park (ASURP), is now open and offering the latest cancer treatment services available to patients in Phoenix and […]
Read More
